Evidence map›Paper›PMID 40593204›Full record

ArticleScientific reports2025

PGL-EXPO feasibility study of exposure to SDHi fungicides and risk of hereditary SDHx paraganglioma or pheochromocytoma.

Astrid Coste, Alexandre Buffet, Margaux Duboeuf, Sabrina Boudif, Lény Grassot, Boutheina Ouelaa, Annabelle Sueur, Timgad Lounis, Olivia Pérol, Béatrice Fervers and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Astrid CosteDepartment of Prevention Cancer Environment, Centre Léon Bérard, Lyon, France. astrid.coste@lyon.unicancer.fr.
Alexandre BuffetService de Médecine Génomique des Tumeurs et des Cancers, AP-HP, Hôpital Européen Georges Pompidou, Fédération de Génétique et de Médecine Génomique, Paris, F-75015, France.
Margaux DuboeufDepartment of Prevention Cancer Environment, Centre Léon Bérard, Lyon, France.
Sabrina BoudifUnité de Recherche Clinique, AP-HP, Hôpital Européen Georges Pompidou, Paris, F-75015, France.
Lény GrassotDepartment of Prevention Cancer Environment, Centre Léon Bérard, Lyon, France.
Boutheina OuelaaService de Médecine Génomique des Tumeurs et des Cancers, AP-HP, Hôpital Européen Georges Pompidou, Fédération de Génétique et de Médecine Génomique, Paris, F-75015, France.
Annabelle SueurDepartment of Prevention Cancer Environment, Centre Léon Bérard, Lyon, France.
Timgad LounisService de Médecine Génomique des Tumeurs et des Cancers, AP-HP, Hôpital Européen Georges Pompidou, Fédération de Génétique et de Médecine Génomique, Paris, F-75015, France.
Olivia PérolDepartment of Prevention Cancer Environment, Centre Léon Bérard, Lyon, France.
Béatrice FerversDepartment of Prevention Cancer Environment, Centre Léon Bérard, Lyon, France.
Anne-Paule Gimenez-RoqueploService de Médecine Génomique des Tumeurs et des Cancers, AP-HP, Hôpital Européen Georges Pompidou, Fédération de Génétique et de Médecine Génomique, Paris, F-75015, France.

Funding

Agence Nationale de Sécurité Sanitaire de l'Alimentation, de l'Environnement et du Travail ANSES, N° 2022-CS-01_PPV22
6 · The paper itself

Abstract

Paraganglioma and pheochromocytoma (PPGL) are rare neuroendocrine tumors with a strong genetic component. SDHx genes are well-known PPGL susceptibility genes. A role of environmental factors, such as succinate dehydrogenase inhibitor (SDHi) fungicides, is suspected in PPGL tumorigenesis. We evaluated the feasibility of a case-control study investigating the association between pesticides, focusing on SDHi fungicides, and the risk of SDHx-related PPGL. The study was conducted in a single referral center between March and June 2022. Cases were patients with PPGL and an SDHx germline mutation diagnosed between 2000 and 2021. Controls, were selected among relatives of cases, diagnosed as SDHx mutation carriers by a presymptomatic genetic test and without PPGL after tumor screening tests. A matching process was formulated to prioritize cases and controls that could be matched according to date of birth, type of gene mutated and distinct family. Phone interviews were used to collect data on general characteristics, PPGL risk factors, the domestic use of pesticides, residential history, occupational history. Addresses were geocoded. The presence of crops within a buffer of 1,500 m was estimated for residential addresses at diagnosis. The probability of occupational exposures to SDHi fungicides was assessed based on the French crop-exposure matrix PESTIMAT. An information letter was sent to 138 subjects out of the 193 followed-up by the center. The prioritization of recruitment was defined by the matching potential of each subject. Overall, 110 subjects were reached by phone, 101 accepted to be included, and 42 cases and 40 controls were interviewed (response rate: 81%). Missing data on domestic exposure to pesticides were more frequent for the households most back-in-time. Even for the oldest residential addresses, at least 81% of the addresses had a precise geocoding. In a buffer with a radius of 1500 m, arable land was present for 55% of subjects' addresses, vineyards and orchards for 5% and 3.8% respectively. Two subjects might have been exposed to SDHi fungicides in the occupational context. Our study showed high participation and response rates. Exposure to pesticides could be assessed with moderate to good precision, even for exposures far back in time.

Indexed as

Adrenal Gland NeoplasmsEnvironmental ExposureFungicides, IndustrialParagangliomaPheochromocytomaSuccinate DehydrogenaseAdultAgedCase-Control StudiesFeasibility StudiesFemaleGenetic Predisposition to DiseaseGerm-Line MutationHumansMaleMiddle AgedFungicides, IndustrialSuccinate DehydrogenaseCase-control studyFeasibility studyHereditary paragangliomaSDH geneSDHi fungicides

Identifiers

PMID40593204
PMCPMC12215505

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.